Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arterial Function and Atherosclerosis in Patients With JAK2 V167F Positive Essential Thrombocythemia

NCT03828422 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT03828422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03828422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arterial Function and Atherosclerosis in Patients With JAK2 V167F Positive Essential Thrombocythemia
Lead sponsor
University Medical Centre Ljubljana
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
August 5, 2021
Enrollment
82 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis